U.S. Appeals Court Rules For Natco, Mylan In MS Drug Patent Case
This article was originally published in PharmAsia News
Executive Summary
Natco Pharma said it has won a U.S. appeals court decision allowing it and its marketing partner, Mylan Laboratories, to launch its generic of Copaxone (glatiramer) multiple sclerosis drug of Teva Pharmaceuticals beginning next May.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.